BMS-279700 is a potent oral activity inhibitor that is part of a new family of aniline 5-azimidazolaquoxaline analogs and has excellent anti-inflammatory activity in vivo, as well as in vitro activity against p56LCK and T cell proliferation, blocking the production of pro-inflammatory cytokines (IL-2 and TNFalpha) in vivo.
Molekulargewicht:
407.9
CAS Nummer:
[240814-54-4]
Formel:
C21H22ClN7
Target-Kategorie:
Others
T30511
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten